News Focus
News Focus
Followers 2372
Posts 118410
Boards Moderated 0
Alias Born 12/17/2011

Re: georgie18 post# 685876

Monday, 06/16/2025 1:32:21 PM

Monday, June 16, 2025 1:32:21 PM

Post# of 723756
IMRX...$2.35...🥳

georgie18

Member Level
Re: georgie18 post# 389758

Monday, June 16, 2025 8:31:26 AM

Post#
394384
of 394426
IMRX...$2.15...🥳... CAMBRIDGE, Mass., June 16, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company outpacing cancer to help patients outlive their disease, today announced that it will host a conference call and live webcast at 8:00 am ET on June 17, 2025. The company is excited to provide updates from its ongoing Phase 2a clinical trial of IMM-1-104 in first-line pancreatic cancer patients.

The conference call will be webcast live and archived in the Investor Relations section of Immuneering’s website at Events & Presentations | Immuneering Corporation.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today